Products
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
Astellas Pharma Taiwan, Inc.
🇹🇼
Taiwan
Country
🇹🇼
Taiwan
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms
Phase 4
Completed
Conditions
Lower Urinary Tract Symptoms
Overactive Bladder
Benign Prostatic Hyperplasia (BPH)
Interventions
Drug: Tamsulosin
Drug: Solifenacin
Subscribe
First Posted Date
2016-03-22
Last Posted Date
2016-03-22
Lead Sponsor
Astellas Pharma Taiwan, Inc.
Target Recruit Count
52
Registration Number
NCT02715024
Locations
🇨🇳
Site, Taipei, Taiwan
Subscribe
A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With Gout
Phase 3
Completed
Conditions
Gout
Interventions
Drug: Allopurinol
Drug: febuxostat
Subscribe
First Posted Date
2012-11-29
Last Posted Date
2014-10-29
Lead Sponsor
Astellas Pharma Taiwan, Inc.
Target Recruit Count
109
Registration Number
NCT01736514
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy